Answers are grounded in this paper and cite their sources.
Supplementary Figure S4 presents flow cytometric analysis of PD-1, TIGIT, and CD226 expression on GD2-2840z-CARTs and GD2-CARrejTs after coculture with SCLC-J1 cells, based on three independent experiments. It also features real-time cell analysis (RTCA) showing tumor proliferation indices over 80 hours in various conditions: alone, in coculture with GD2-CARrejTs, and control T cells, with and without anti-TIGIT and anti-PD-1 antibodies. The data illustrate the effect of these treatments on tumor growth.
No takes yet. Share an insight, caveat, or question.
Kinoshita et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: